首站-论文投稿智能助手
典型文献
Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis
文献摘要:
Background:Primary biliary cholangitis(PBC)patients often have concomitant extrahepatic autoimmune(EHA)diseases including Sj?gren's syndrome(SS),systemic sclerosis(SSc),rheumatoid arthritis(RA),and autoimmune thyroid disease.The present study aimed to describe the prevalence of EHA diseases in PBC and explore the impact of EHA diseases on the long-term outcomes of PBC in Chinese patients.Methods:Medical records of PBC patients diagnosed in our institute were retrospectively reviewed.Pa-tients were followed up by a standardized telephone interview.The endpoints were defined as liver-related death and/or liver transplantation.Results:Totally 247 of the 985(25.1%)PBC patients enrolled in the study had at least one concomi-tant EHA disease.Sj?gren's syndrome(n=140,14.2%)was the most frequent one,followed by rheuma-toid arthritis(RA)(n=56,5.7%)and Hashimoto's thyroiditis(n=45,4.6%).Patients with EHA dis-eases were more common in females(P<0.001)and in those with a family history of autoimmune disease(P=0.017).Overall,no differences were found between PBC patients with and without EHA dis-eases in terms of biochemical response rates to ursodeoxycholic acid,the incidence of hepatic events,or transplant-free survival.RA and EHA≥2 were protective factors for hepatic events in univariate Cox analysis,but the results became insignificant in multivariate analysis.Conclusions:Concomitant EHA diseases were common in PBC patients but did not compromise the long-term outcomes of PBC.
文献关键词:
作者姓名:
Sha Chen;Meng-Qi Li;Wei-Jia Duan;Bu-Er Li;Shu-Xiang Li;Ting-Ting Lv;Lin Ma;Ji-Dong Jia
作者机构:
Liver Research Center,Beijing Friendship Hospital,Capital Medical University!Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis!National Clinical Research Center for Digestive Diseases,95 Yong'an Road,Beijing 100050,China
引用格式:
[1]Sha Chen;Meng-Qi Li;Wei-Jia Duan;Bu-Er Li;Shu-Xiang Li;Ting-Ting Lv;Lin Ma;Ji-Dong Jia-.Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis)[J].国际肝胆胰疾病杂志(英文版),2022(06):577-582
A类:
concomi
B类:
Concomitant,extrahepatic,autoimmune,diseases,do,not,compromise,long,outcomes,primary,biliary,cholangitis,Background,Primary,PBC,patients,often,have,concomitant,EHA,including,Sj,gren,syndrome,systemic,sclerosis,SSc,rheumatoid,arthritis,RA,present,study,aimed,describe,prevalence,explore,impact,Chinese,Methods,Medical,records,diagnosed,our,institute,were,retrospectively,reviewed,followed,up,by,standardized,telephone,interview,endpoints,defined,liver,related,death,transplantation,Results,Totally,enrolled,had,least,was,most,frequent,Hashimoto,thyroiditis,Patients,more,common,females,those,family,history,Overall,differences,found,between,without,terms,biochemical,response,rates,ursodeoxycholic,acid,incidence,events,free,survival,protective,factors,univariate,Cox,analysis,but,results,became,insignificant,multivariate,Conclusions,did
AB值:
0.494789
相似文献
Homeopathy for COVID-19 in primary care:A randomized,double-blind,placebo-controlled trial(COVID-Simile study)
Ubiratan Cardinalli Adler;Maristela Schiabel Adler;Ana Elisa Madureira Padula;Livia Mitchiguian Hotta;Amarilys de Toledo Cesar;José Nelson Martins Diniz;Helen de Freitas Santos;Edson Zangiacomi Martinez-Department of Medicine,Federal University of S?o Carlos,S?o Carlos 13565-905,Brazil;Homeopathy Solidarity Outpatient Extension Program,Mackenzie Presbyterian University,S?o Paulo 01302-907,Brazil;Municipal Center for Integrative and Complementary Practices in Health,Guarulhos 07023-051,Brazil;HN-Cristiano Institute,S?o Paulo 02013-001,Brazil;School Health Unit,Federal University of S?o Carlos,Sao Carlos 13565-905,Brazil;Federal Institute of Education,Science and Technology of S?o Paulo,Birigui 16201-407,Brazil;Department of Social Medicine,Ribeir?o Preto Medical School,University of Sao Paulo,Ribeirao Preto 14049-900,Brazil
Prognostic nomogram incorporating radiological features for predicting overall survival in patients with AIDS-related non-Hodgkin lymphoma
Li Xueqin;Pan Ziang;Wang Xing;Hu Tianli;Ye Wen;Jiang Dongmei;Shen Wen;Liu Jinxin;Shi Yuxin;Xia Shuang;Li Hongjun-Radiological Department, Beijing You'an Hospital Affiliated of Capital Medical University, Beijing 100069, China;Neurological Department, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;Radiological Department, The Eighth People's Hospital of Guangzhou, Guangzhou, Guangdong 510060, China;Radiological Department, Shanghai Public Health Clinical Center, Affiliated of Fudan University, Shanghai 201058, China;Radiation Department, Tianjin First Central Hospital, Tianjin 300170, China;Radiological Department, Tianjin First Central Hospital, Tianjin 300192, China
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
Gui Yinli;Bai Wei;Xu Jian;Duan Xinwang;Zhan Feng;Zhao Chen;Jiang Zhenyu;Li Zhijun;Wu Lijun;Liu Shengyun;Yang Min;Wei Wei;Wang Ziqian;Zhao Jiuliang;Wang Qian;Leng Xiaomei;Tian Xinping;Li Mengtao;Zhao Yan;Zeng Xiaofeng;CSTAR co-authors-Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China;Department of Rheumatology, The People’s Hospital of Zhengzhou, Zhengzhou, Henan 450003, China;Department of Rheumatology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China;Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China;Department of Rheumatology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, China;Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;Department of Rheumatology, The Bethune First Hospital of Jilin University, Changchun, Jilin 130021, China;Department of Rheumatology, The Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China;Department of Rheumatology, The People’s Hospital of Xinjiang Autonomous Region, Urumqi, Xinjiang 830001, China;Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;Department of Rheumatology, Tianjin Medical University General Hospital, Tianjin 300052, China
Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study
Li Jielin;Hu Jiexuan;Li Peng;Wu Yongdong;Wang Yongjun;Ji Ming;Hua Haiyang;Ran Wenbin;Pan Yanglin;Zhang Shutian-Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China;Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Department of Gastroenterology, Cheng De Central Hospital, Chengde, Hebei 067000, China;Department of Gastroenterology, The Third People’s Hospital of Chengdu, Chengdu, Sichuan 610031, China;Xijing Hospital of Digestive Diseases, Air Force Medical University of People’s Liberation Army, Xi’an, Shaanxi 710032, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
The predictors of long-COVID in the cohort of Turkish Thoracic Society-TURCOVID multicenter registry: One year follow-up results
Serap Argun Baris;Oya Baydar Toprak;Pelin Duru Cetinkaya;Fusun Fakili;Nurdan Kokturk;Seval Kul;Ozgecan Kayalar;Yildiz Tutuncu;Emel Azak;Mutlu Kuluozturk;Pinar Aysert Yildiz;Pelin Pinar Deniz;Oguz Kilinc;Ilknur Basyigit;Hasim Boyaci;Ismail Hanta;Neslihan Kose;Gulseren Sagcan;Caglar Cuhadaroglu;Hacer Kuzu Okur;Hasan Selcuk Ozger;Begum Ergan;Mehtap Hafizoglu;Abdullah Sayiner;Esra Nurlu Temel;Onder Ozturk;Tansu Ulukavak Ciftci;Ipek Kivilcim Oguzulgen;Vildan Avkan Oguz;Firat Bayraktar;Ozlem Ataoglu;Merve Ercelik;Pinar Yildiz Gulhan;Aysegul Tomruk Erdem;Muge Meltem Tor;Oya Itil;Hasan Bayram-Department of Pulmonary Medicine,Faculty of Medicine,Kocaeli University,Kocaeli,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Cukurova University,Adana,Turkey;Department of Pulmonary Medicine,University of Health Sciences,Adana City Training and Research Hospital,Adana,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Gaziantep University,Gaziantep,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Gazi University,Ankara,Turkey;Department of Biostatistics,Faculty of Medicine,Gaziantep University,Gaziantep,Turkey;Koc University Research Center for Translational Medicine(KUTTAM),Koc University School of Medicine,Istanbul,Turkey;Department of Immunology,Koc University Research Center for Translational Medicine(KUTTAM),Koc University School of Medicine,Istanbul,Turkey;Department of Infectious Disease and Clinical Microbiology,Faculty of Medicine,Kocaeli University,Kocaeli Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Firat University,Elazig,Turkey;Department of Infectious Diseases and Clinical Microbiology,Faculty of Medicine,Gazi University,Ankara,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Dokuz Eylul University,Izmir,Turkey;Department of Pulmonary Medicine,Bilecik Training and Research Hospital,Bilecik,Turkey;Department of Pulmonary Medicine,Altunizade Acibadem Hospital,Istanbul,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Ege University,Izmir,Turkey;Department of Infectious Diseases and Clinical Microbiology,Faculty of Medicine,Suleyman Demirel University,Isparta,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Suleyman Demirel University,Isparta,Turkey;Department of Infectious Disease and Clinical Microbiology,Faculty of Medicine,Dokuz Eylul University,Izmir,Turkey;Department of Internal Medicine,Faculty of Medicine,Dokuz Eylul University,Izmir,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Duzce University,Duzce,Turkey;Department of Pulmonary Medicine,Faculty of Medicine,Zonguldak Bulent Ecevit University,Zonguldak,Turkey;Department of Pulmonary Medicine,Koc University Research Center for Translational Medicine(KUTTAM),Koc University School of Medicine,Istanbul,Turkey
Does reconstruction affect outcomes following exclusively endoscopic endonasal resection of benign orbital tumors: A systematic review with meta-analysis
Lehmann Ashton E.;von Sneidern Manuela;Shen Sarek A.;Humphreys Ian M.;Abuzeid Waleed M.;Jafari Aria-Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA;Department of Otolaryngology-Head and Neck Surgery, Geisinger Medical Center, Danville, Pennsylvania, USA;Department of Otolaryngology-Head and Neck Surgery, New York University School of Medicine, New York, New York, USA;Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA;Division of Rhinology and Endoscopic Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer:A real-world,multicenter,retrospective,controlled study in China
Hanxiao Chen;Xiangjuan Ma;Jie Liu;Yu Yang;Yong Fang;Liping Wang;Jian Fang;Jun Zhao;Minglei Zhuo-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅰ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅱ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Pneumology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China;Department of Oncology,the 2nd Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Oncology,Sir Run Run Shaw Hospital Zhejiang University School of Medicine,Hangzhou 310020,China;Department of Oncology,Baotou Cancer Hospital,Baotou 014030,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。